Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial
[...]improvement in symptoms is very difficult to prove because of their subjective nature. [...]because double-blind assessment is almost impossible and there is potential for a placebo effect, symptom improvement by itself cannot be used as a sole reliable endpoint.\n What is a Safe Procedure? [.....
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2016-06, Vol.67 (25), p.2937-2940 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2940 |
|---|---|
| container_issue | 25 |
| container_start_page | 2937 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 67 |
| creator | Kapadia, Samir R. Krishnaswamy, Amar Tuzcu, E. Murat |
| description | [...]improvement in symptoms is very difficult to prove because of their subjective nature. [...]because double-blind assessment is almost impossible and there is potential for a placebo effect, symptom improvement by itself cannot be used as a sole reliable endpoint.\n What is a Safe Procedure? [...]preserving future options for treatment is another important "safety" feature, and it appears that the Mitralign technology may fulfill this criterion, as 7 patients in the treated group underwent subsequent MitraClip (Abbott Vascular, Santa Clara, California) placement and 1 underwent MV surgery. |
| doi_str_mv | 10.1016/j.jacc.2016.04.028 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808693360</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109716329217</els_id><sourcerecordid>1799561367</sourcerecordid><originalsourceid>FETCH-LOGICAL-e240t-2b8035b852eff22cfbb84e9b5c3d38908f235f5f1aede6ac8906638e61582bd93</originalsourceid><addsrcrecordid>eNqFkU1LxDAQhoMoun78AQ9S8OKldZI0aSJeFnVVWNCDnkOaTiGl265JK-y_t-vqxYunGYaHF-Z9CDmnkFGg8rrJGutcxqY9gzwDpvbIjAqhUi50sU9mUHCRUtDFETmOsQEAqag-JEes4FznGmbk-RWDGwfbYT_G5N4HdEMy77qx7detjcPmJllijH0Xk0XoV4ntkgcb2k2yQBt96Vs_bJK34G17Sg5q20Y8-5kn5H3x8Hb3lC5fHp_v5ssUWQ5DykoFXJRKMKxrxlxdlipHXQrHK640qJpxUYuaWqxQWjedpOQKJRWKlZXmJ-Rql7sO_ceIcTArHx227e4HQxUoqTmX8D9aaC0k5bKY0Ms_aNOPoZse2QZCIaXg-URd_FBjucLKrINf2bAxv31OwO0OwKmBT4_BROexc1h9N2uq3hsKZqvPNGarz2z1GcjNpI9_AW2Fiz4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1800766534</pqid></control><display><type>article</type><title>Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kapadia, Samir R. ; Krishnaswamy, Amar ; Tuzcu, E. Murat</creator><creatorcontrib>Kapadia, Samir R. ; Krishnaswamy, Amar ; Tuzcu, E. Murat</creatorcontrib><description>[...]improvement in symptoms is very difficult to prove because of their subjective nature. [...]because double-blind assessment is almost impossible and there is potential for a placebo effect, symptom improvement by itself cannot be used as a sole reliable endpoint.\n What is a Safe Procedure? [...]preserving future options for treatment is another important "safety" feature, and it appears that the Mitralign technology may fulfill this criterion, as 7 patients in the treated group underwent subsequent MitraClip (Abbott Vascular, Santa Clara, California) placement and 1 underwent MV surgery.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2016.04.028</identifier><identifier>PMID: 27339490</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bailouts ; Calcification ; Cardiology ; Cardiovascular disease ; Feasibility studies ; Heart attacks ; heart failure ; mitral regurgitation ; Mitral Valve ; Mitral Valve Annuloplasty ; Mitral Valve Insufficiency ; Mortality ; Patients ; percutaneous annuloplasty ; Surgery ; Tricuspid Valve</subject><ispartof>Journal of the American College of Cardiology, 2016-06, Vol.67 (25), p.2937-2940</ispartof><rights>2016 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jun 28, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2016.04.028$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27339490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kapadia, Samir R.</creatorcontrib><creatorcontrib>Krishnaswamy, Amar</creatorcontrib><creatorcontrib>Tuzcu, E. Murat</creatorcontrib><title>Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>[...]improvement in symptoms is very difficult to prove because of their subjective nature. [...]because double-blind assessment is almost impossible and there is potential for a placebo effect, symptom improvement by itself cannot be used as a sole reliable endpoint.\n What is a Safe Procedure? [...]preserving future options for treatment is another important "safety" feature, and it appears that the Mitralign technology may fulfill this criterion, as 7 patients in the treated group underwent subsequent MitraClip (Abbott Vascular, Santa Clara, California) placement and 1 underwent MV surgery.</description><subject>Bailouts</subject><subject>Calcification</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Feasibility studies</subject><subject>Heart attacks</subject><subject>heart failure</subject><subject>mitral regurgitation</subject><subject>Mitral Valve</subject><subject>Mitral Valve Annuloplasty</subject><subject>Mitral Valve Insufficiency</subject><subject>Mortality</subject><subject>Patients</subject><subject>percutaneous annuloplasty</subject><subject>Surgery</subject><subject>Tricuspid Valve</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1LxDAQhoMoun78AQ9S8OKldZI0aSJeFnVVWNCDnkOaTiGl265JK-y_t-vqxYunGYaHF-Z9CDmnkFGg8rrJGutcxqY9gzwDpvbIjAqhUi50sU9mUHCRUtDFETmOsQEAqag-JEes4FznGmbk-RWDGwfbYT_G5N4HdEMy77qx7detjcPmJllijH0Xk0XoV4ntkgcb2k2yQBt96Vs_bJK34G17Sg5q20Y8-5kn5H3x8Hb3lC5fHp_v5ssUWQ5DykoFXJRKMKxrxlxdlipHXQrHK640qJpxUYuaWqxQWjedpOQKJRWKlZXmJ-Rql7sO_ceIcTArHx227e4HQxUoqTmX8D9aaC0k5bKY0Ms_aNOPoZse2QZCIaXg-URd_FBjucLKrINf2bAxv31OwO0OwKmBT4_BROexc1h9N2uq3hsKZqvPNGarz2z1GcjNpI9_AW2Fiz4</recordid><startdate>20160628</startdate><enddate>20160628</enddate><creator>Kapadia, Samir R.</creator><creator>Krishnaswamy, Amar</creator><creator>Tuzcu, E. Murat</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160628</creationdate><title>Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial</title><author>Kapadia, Samir R. ; Krishnaswamy, Amar ; Tuzcu, E. Murat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e240t-2b8035b852eff22cfbb84e9b5c3d38908f235f5f1aede6ac8906638e61582bd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Bailouts</topic><topic>Calcification</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Feasibility studies</topic><topic>Heart attacks</topic><topic>heart failure</topic><topic>mitral regurgitation</topic><topic>Mitral Valve</topic><topic>Mitral Valve Annuloplasty</topic><topic>Mitral Valve Insufficiency</topic><topic>Mortality</topic><topic>Patients</topic><topic>percutaneous annuloplasty</topic><topic>Surgery</topic><topic>Tricuspid Valve</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kapadia, Samir R.</creatorcontrib><creatorcontrib>Krishnaswamy, Amar</creatorcontrib><creatorcontrib>Tuzcu, E. Murat</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kapadia, Samir R.</au><au>Krishnaswamy, Amar</au><au>Tuzcu, E. Murat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2016-06-28</date><risdate>2016</risdate><volume>67</volume><issue>25</issue><spage>2937</spage><epage>2940</epage><pages>2937-2940</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]improvement in symptoms is very difficult to prove because of their subjective nature. [...]because double-blind assessment is almost impossible and there is potential for a placebo effect, symptom improvement by itself cannot be used as a sole reliable endpoint.\n What is a Safe Procedure? [...]preserving future options for treatment is another important "safety" feature, and it appears that the Mitralign technology may fulfill this criterion, as 7 patients in the treated group underwent subsequent MitraClip (Abbott Vascular, Santa Clara, California) placement and 1 underwent MV surgery.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27339490</pmid><doi>10.1016/j.jacc.2016.04.028</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2016-06, Vol.67 (25), p.2937-2940 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1808693360 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Bailouts Calcification Cardiology Cardiovascular disease Feasibility studies Heart attacks heart failure mitral regurgitation Mitral Valve Mitral Valve Annuloplasty Mitral Valve Insufficiency Mortality Patients percutaneous annuloplasty Surgery Tricuspid Valve |
| title | Percutaneous Direct Annuloplasty: Lessons From an Early Feasibility Trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T18%3A35%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Percutaneous%20Direct%20Annuloplasty:%20Lessons%20From%20an%20Early%20Feasibility%20Trial&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Kapadia,%20Samir%20R.&rft.date=2016-06-28&rft.volume=67&rft.issue=25&rft.spage=2937&rft.epage=2940&rft.pages=2937-2940&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2016.04.028&rft_dat=%3Cproquest_pubme%3E1799561367%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1800766534&rft_id=info:pmid/27339490&rft_els_id=S0735109716329217&rfr_iscdi=true |